Novel nucleic acid molecules
US-2016024522-A1 · Jan 28, 2016 · US
US9981908B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9981908-B2 |
| Application number | US-201414910107-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 4, 2014 |
| Priority date | Aug 5, 2013 |
| Publication date | May 29, 2018 |
| Grant date | May 29, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There are provided pyrrolysine analogs of the formulae (X), (I), (II), (V), (VI), (VII) and (VIII), in which the a, b, d, X, Y, Z, FG, R, R 1 , R 2 and R 3 are as defined in the claims, which are useful in bioconjugation processes and mutant proteins containing them.
Opening claim text (preview).
The invention claimed is: 1. A pyrrolysine analogue of formula X: wherein X=O or S; Y=CH 2 , NH, O or S; Z=CH 2 , CH—NH 2 , CH—OH, NH, O or S; FG azide, alkene, alkyne, ketone, ester, or cycloalkyne; a=an integer 1-7; b=an integer 1-7 save that when Z is NH, O or S then b is an integer 2-7; provided that a+h is in the range 2-8; and d=an integer 1-4. 2. A pyrrolysine analogue according to claim 1 which is a pyrrolysine analogue of formula III: wherein a, b, Z, d and FG are as defined in claim 1 . 3. A pyrrolysine analogue according to claim 2 selected from 4. A pyrrolysine analogue according to claim 1 which is a pyrrolysine analogue of Formula IV: wherein a, b, Y, Z, d and FG are as defined in claim 1 . 5. A pyrrolysine analogue according to claim 4 selected from 6. A pyrrolysine analogue of formula I: wherein Z=bond, CH 2 , CH—NH 2 , CH—OH, NH, O, S or CH—NH 2 ; a is an integer 3-7; b is 0 or an integer 1-7; and FG=azide, alkene, alkyne, ketone, ester, or cycloalkyne; with the provisos that: when a represents 4 and Z represents O, —(CH 2 ) b -FG does not represent —CH 2 —C≡CH, —CH 2 CH 2 —N 3 , —CH 2 —CH═CH 2 or —CH 2 -Ph; when a represents 4 and Z represents O, —(CH 2 ) b -FG does not represent —CH 2 CH 2 CH 2 —C(═O)CH 3 or —CH 2 CH 2 CH 2 —CH═CH 2 ; when a represents 4, Z represents a bond and b represents 0, —(CH 2 ) b -FG does not represent —C(═O)Bn or —C(═O)Me; and when a represents 4 and Z represents a bond, —(CH 2 ) b -FG does not represent —CH 2 CH 2 —C≡CH. 7. A pyrrolysine analogue according to claim 6 selected from 8. A pyrrolysine analogue according to claim 6 selected from 9. A pyrrolysine analogue of formula II: wherein Z=CH 2 , CH—NH 2 , CH—OH, NH, O or S; FG=azide, alkene, alkyne, ketone, ester, aryl or cycloalkyne; a=an integer 3 or 5-7; and b=an integer 1-4. 10. A pyrrolysine analogue of formula V: wherein R=the side chain of one of the 20 natural amino acids; Z=CH 2 , CH—NH 2 , CH—OH, NH, O or S; FG=azide, alkene, alkyne, ketone, ester, aryl or cycloalkyne; a=1; and b=an integer 1 to 4. 11. A pyrrolysine analogue according to claim 10 selected from 12. A pyrrolysine analogue of formula VI: wherein Z=CH 2 , CH—NH 2 , CH—OH, NH, O or S; PG=azide, alkene, alkyne, ketone, ester, or cycloalkyne; a=4 or 5; and b=an integer 1 to 4. 13. A pyrrolysine analogue according to claim 12 selected from 14. A pyrrolysine analogue of formula VII: wherein R=alkyl, alkenyl, cycloalkyl, aryl, heteroaryl or heterocyclyl; a=an integer 1 to 7; and b=an integer 1 to 3. 15. A pyrrolysine analogue according to claim 14 which is: 16. A pyrrolysine analogue of formula VIII: wherein Z=CH 2 , CH—NH 2 , CH—OH, NH, O or S; R 1 =H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl or heterocyclyl; R 2 =alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl or heterocyclyl; R 3 =H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl or heterocyclyl; and a=1. 17. A pyrrolysine analogue according to claim 16 selected from 18. A pyrrolysine analogue according to 3 wherein the pyrrolysine analogue is 19. A pyrrolysine analogue according to 3 , wherein the pyrrolysine analogue is 20. A pyrrolysine analogue according to 3 , wherein the pyrrolysine analogue is 21. A pyrrolysine analogue according to 3 , wherein the pyrrolysine analogue is 22. A pyrrolysine analogue according to 3 , wherein the pyrrolysine analogue is 23. A pyrrolysine analogue according to 7 , wherein the pyrrolysine analogue is 24. A pyrrolysine analogue according to 11 , wherein the pyrrolysine analogue is 25. A pyrrolysine analogue according to 11 , wherein the pyrrolysine analogue is 26. A pyrrolysine analogue according to 17 , wherein the pyrrolysine analogue is
to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title
characterized by post-translational modification · CPC title
to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals · CPC title
of an unsaturated carbon skeleton · CPC title
to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.